These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26810135)

  • 1. Impact of germline and somatic missense variations on drug binding sites.
    Yan C; Pattabiraman N; Goecks J; Lam P; Nayak A; Pan Y; Torcivia-Rodriguez J; Voskanian A; Wan Q; Mazumder R
    Pharmacogenomics J; 2017 Mar; 17(2):128-136. PubMed ID: 26810135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Nonsynonymous Single-Nucleotide Variations on Post-Translational Modification Sites in Human Proteins.
    Gulzar N; Dingerdissen H; Yan C; Mazumder R
    Methods Mol Biol; 2017; 1558():159-190. PubMed ID: 28150238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
    Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
    BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.
    Liu Y; Loewer M; Aluru S; Schmidt B
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):47. PubMed ID: 27489955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment (HIVE).
    Wu TJ; Shamsaddini A; Pan Y; Smith K; Crichton DJ; Simonyan V; Mazumder R
    Database (Oxford); 2014; 2014():bau022. PubMed ID: 24667251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial distribution of disease-associated variants in three-dimensional structures of protein complexes.
    Gress A; Ramensky V; Kalinina OV
    Oncogenesis; 2017 Sep; 6(9):e380. PubMed ID: 28945216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces.
    Engin HB; Kreisberg JF; Carter H
    PLoS One; 2016; 11(4):e0152929. PubMed ID: 27043210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution bias analysis of germline and somatic single-nucleotide variations that impact protein functional site and neighboring amino acids.
    Pan Y; Yan C; Hu Y; Fan Y; Pan Q; Wan Q; Torcivia-Rodriguez J; Mazumder R
    Sci Rep; 2017 Feb; 7():42169. PubMed ID: 28176830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
    Greenblatt MS; Beaudet JG; Gump JR; Godin KS; Trombley L; Koh J; Bond JP
    Oncogene; 2003 Feb; 22(8):1150-63. PubMed ID: 12606942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identify drug repurposing candidates by mining the protein data bank.
    Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
    Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.
    Altmüller J; Haenisch B; Kawalia A; Menzen M; Nöthen MM; Fier H; Molderings GJ
    Immunogenetics; 2017 Jun; 69(6):359-369. PubMed ID: 28386644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human germline and pan-cancer variomes and their distinct functional profiles.
    Pan Y; Karagiannis K; Zhang H; Dingerdissen H; Shamsaddini A; Wan Q; Simonyan V; Mazumder R
    Nucleic Acids Res; 2014 Oct; 42(18):11570-88. PubMed ID: 25232094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Text Mining for Precision Medicine: Bringing Structure to EHRs and Biomedical Literature to Understand Genes and Health.
    Simmons M; Singhal A; Lu Z
    Adv Exp Med Biol; 2016; 939():139-166. PubMed ID: 27807747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and assessment of individualized proteogenomic databases for large-scale analysis of nonsynonymous single nucleotide variants.
    Krug K; Popic S; Carpy A; Taumer C; Macek B
    Proteomics; 2014 Dec; 14(23-24):2699-708. PubMed ID: 25251379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F1 somatic mutation within miRNA target site impairs gene regulation in colorectal cancer.
    Lopes-Ramos CM; Barros BP; Koyama FC; Carpinetti PA; Pezuk J; Doimo NTS; Habr-Gama A; Perez RO; Parmigiani RB
    PLoS One; 2017; 12(7):e0181153. PubMed ID: 28704519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.